+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Airway Clearance System Market by type, Application: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5031506
  • Report
  • March 2020
  • Region: Global
  • 207 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Allergan plc
  • Dymedso Inc.
  • Electromed Inc. Ltd.
  • PARI GmbH
  • Thayer Medical
The global airway clearance system market was valued at $652 million in 2018 and is expected to reach $922 million by 2026, registering a CAGR of 4.7 from 2019 to 2026.Airway clearance techniques are used to slacken thick, sticky mucus so it can be cleared from lungs by coughing or huffing. Clearing the airways may help to reduce lung infections and improve lung function. There are some methods that help people suffering with conditions such as cystic fibrosis to attain a healthier lifestyle. ACTs are physical or mechanical means of simplifying the elimination of tracheobronchial phlegm through the external or internal management of air flow, and the removal of phlegm via coughing. These products loosen thick, sticky lung mucus so it can be cleared by coughing. Clearing the mucus from the airways helps in lowering lung infections and improve lung function. These airway clearance devices find their application in the treatment of various disorders including emphysema, cystic fibrosis, neuromuscular, bronchiectasis and others.

Rise in The prevalence of cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD) across the globe is the major factor driving the airway clearance market growth. The growth of the market would be enhanced due to increase in healthcare expenditure, growth in the use of automation in healthcare industry, and rapid adoption of advanced medical solutions. Currently, most of healthcare practitioners and pulmonary diseases specialists prefer a combination of a drug and a device, for instance inhaler and nebulizer, owing to its fast and effective outcome. However, the market growth could be hindered due to high cost associated with the airway clearance systems and side effects occurring due to excessive dosage, and lack of awareness regarding drug inhalation.

The market is segmented on the basis of type, application, end user, and region. By type, it is bifurcated into positive expiratory pressure, high frequency chest wall oscillation, oscillating pep devices, intrapulmonary percussive ventilators and mechanical cough assist. Based on application, the market is segregated into emphysema, cystic fibrosis, neuromuscular bronchiectasis. By end-users it is segmented it is classified into hospital & clinics, ambulatory surgical centers, homecare settings and others Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Type
  • Positive Expiratory Pressure (PEP)
  • High Frequency Chest Wall Oscillation (HFCWO)
  • Oscillating PEP devices
  • Intrapulmonary Percussive Ventilators
  • Mechanical Cough Assist

By Application
  • Emphysema
  • Cystic fibrosis
  • Neuromuscular
  • Bronchiectasis
  • Others

By End-User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

By Geography
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Allergan Plc
  • Dymedso Inc
  • Electromed Inc
  • General Physiotherapy Inc
  • Hill-Rom Holdings, Inc.
  • International Biophysical Corporation
  • Koninklijke Philips N.V. (Philips)
  • Monaghan Medical Corporation
  • PARI GmbH
  • Thayer Medical
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan plc
  • Dymedso Inc.
  • Electromed Inc. Ltd.
  • PARI GmbH
  • Thayer Medical

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of buyers
3.3.2. Low bargaining power of suppliers
3.3.3. Moderate threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate competitive rivalry
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in incidence of cystic fibrosis (CF)
3.5.1.2. Surge in government initiatives towards controlling respiratory disorders
3.5.2. Restraint
3.5.2.1. Low awareness regarding cystic fibrosis in developing nations
3.5.3. Opportunity
3.5.3.1. Various growth opportunities in emerging economies
CHAPTER 4: AIRWAY CLEARANCE SYSTEMS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Positive Expiratory Pressure (PEP)
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market share analysis, by country
4.3. High Frequency Chest High-frequency chest Wall Oscillation (HFCWO)
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country
4.4. Oscillating PEP devices
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country
4.5. Intrapulmonary Percussive Ventilators
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market share analysis, by country
4.6. Mechanical Cough Assist
4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast
4.6.3. Market share analysis, by country
CHAPTER 5: AIRWAY CLEARANCE SYSTEMS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Emphysema
5.2.1. Market size and forecast
5.2.2. Market share analysis, by country
5.3. Cystic fibrosis
5.3.1. Market size and forecast
5.3.2. Market share analysis, by country
5.4. Neuromuscular
5.4.1. Market size and forecast
5.4.2. Market share analysis, by country
5.5. Bronchiectasis
5.5.1. Market size and forecast
5.5.2. Market share analysis, by country
5.6. Others
5.6.1. Market size and forecast
5.6.2. Market share analysis, by country
CHAPTER 6: AIRWAY CLEARANCE SYSTEMS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital & Clinics
6.2.1. Market size and forecast
6.2.2. Market share analysis, by country
6.3. Ambulatory Surgical Centers
6.3.1. Market size and forecast
6.3.2. Market share analysis, by country
6.4. Homecare Settings
6.4.1. Market size and forecast
6.4.2. Market share analysis, by country
CHAPTER 7: AIRWAY CLEARANCE SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by type
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by end user
7.2.5.1. U. S. market size and forecast, by type
7.2.5.2. U. S. market size and forecast, by application
7.2.5.3. U. S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by type
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.7. Mexico market size and forecast, by type
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key growth factors and opportunities
7.3.2. Europe Market size and forecast, by country
7.3.3. Europe Market size and forecast, by type
7.3.4. Europe Market size and forecast, by application
7.3.5. Europe Market size and forecast, by end user
7.3.5.1. Germany market size and forecast, by type
7.3.5.2. Germany market size and forecast, by application
7.3.5.3. Germany market size and forecast, by end user
7.3.5.4. France market size and forecast, by type
7.3.5.5. France market size and forecast, by application
7.3.5.6. France market size and forecast, by end user
7.3.5.7. UK market size and forecast, by type
7.3.5.8. UK market size and forecast, by application
7.3.5.9. UK market size and forecast, by end user
7.3.5.10. Spain market size and forecast, by type
7.3.5.11. Spain market size and forecast, by application
7.3.5.12. Spain market size and forecast, by end user
7.3.5.13. Rest of Europe market size and forecast, by type
7.3.5.14. Rest of Europe market size and forecast, by application
7.3.5.15. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key growth factors and opportunities.
7.4.2. Asia-Pacific market size and forecast, by country
7.4.3. Asia-Pacific market size and forecast, by type
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.4.6.1. Japan market size and forecast, by type
7.4.6.2. Japan market size and forecast, by application
7.4.6.3. Japan market size and forecast, by end user
7.4.6.4. China market size and forecast, by type
7.4.6.5. China market size and forecast, by application
7.4.6.6. China market size and forecast, by end user
7.4.6.7. India market size and forecast, by type
7.4.6.8. India market size and forecast, by application
7.4.6.9. India market size and forecast, by end user
7.4.6.10. Australia market size and forecast by type
7.4.6.11. Australia market size and forecast, by application
7.4.6.12. Australia market size and forecast, by end user
7.4.6.13. Rest of Asia-Pacific market size and forecast by type
7.4.6.14. Rest of Asia-Pacific market size and forecast, by application
7.4.6.15. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key growth factors and opportunities
7.5.2. Market size and forecast, by country
7.5.3. LAMEA market size and forecast, by type
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
7.5.5.1. Brazil market size and forecast, by type
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. Saudi Arabia market size and forecast, by type
7.5.5.5. Saudi Arabia market size and forecast, by application
7.5.5.6. Saudi Arabia market size and forecast, by end user
7.5.5.7. South Africa market size and forecast, by type
7.5.5.8. South Africa market size and forecast, by application
7.5.5.9. South Africa market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by type
7.5.5.11. Rest of LAMEA market size and forecast, by application
7.5.5.12. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Allergan plc
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Dymedso Inc
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.3. Electromed Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segment
8.3.4. Product portfolio
8.3.5. Business performance
8.4. General Physiotherapy Inc
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. HILL-ROM HOLDINGS, INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. International Biophysical Corporation
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. Koninklijke Philips N. V. (Philips)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Monaghan Medical Corporation
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. PARI GmbH.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.10. Thayer Medical
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan plc
  • Dymedso Inc.
  • Electromed Inc. Ltd.
  • PARI GmbH
  • Thayer Medical
According to this report titled, 'Airway clearance market by type, application, and end user: Global opportunity analysis and industry forecast, 2018-2026,' the Airway clearance market size is expected to reach $922million by 2026, registering a CAGR of 4.7% from 2019 to 2026, in terms of value.

The global airway clearance system market was valued at $652 million in 2018 and is expected to reach $922 million by 2026, registering a CAGR of 4.7 from 2019 to 2026. Airway clearance is a therapy are used for loosening the mucus in patients suffering from respiratory disorders such as COPD, asthma, cystic fibrosis and others. Major increase in the incidence of respiratory disorders all-inclusive has led to an increased demand of these devices. For instance, according to the Global Initiative for Asthma (GINA), around 300 million people across the world suffer from asthma every year. Further, COPD, was the 3rd leading cause for death, led to the death of 3 million people in 2017. Moreover, for treating these disorders, a variety of airway clearance systems have been introduced in the market, such as positive expiratory pressure (PEP), high frequency chest wall oscillation (HFCWO. However, the positive expiratory pressure (PEP)is the most effective treatment option as compared to the other methods.

Significant increase in The prevalence of cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD) across the globe is the major factor driving the airway clearance market growth. For instance, U.S. Cystic Fibrosis Foundation, more than 30,000 people are living with cystic fibrosis in the country. Further, the major factors leading the market growth are increasing concerns of respiratory diseases, such as asthma and emphysema, and rising incidence of respiratory diseases caused due to cigarette consumption. The growth of the market would be boosted due to increase in healthcare expenditure, growth in the use of homecare devices in healthcare industry, and rapid adoption of advanced medical solutions. Currently, most of healthcare practitioners and pulmonary diseases experts prefer a combination of a drug and a device, owing to its fast and effective outcome. However, the factors such as high cost correlated with the airway clearance systems and side effects occurring due to their excessive usage may hamper the airway clearance system market growth Technological advancements in airway clearances such as providing minimally invasive treatments, surge in awareness among individuals towards self-grooming are the major factors driving the airway clearances market growth. In addition, rise in disposable incomes in developing economies such as China, India, further contributes to the market growth. However, high cost of these devices and a lack of appropriate reimbursement policies are restraining the growth of this market. On the contrary, rise in baby boomer population and the budding trend of body altering across the globe, are anticipated to create lucrative opportunities for the market in near future. In addition, manufacturers are continuously focusing towards improving their products to help users in gaining improved results in a shorter time period with minimal or no incisions.

By type, the positive expiratory pressure (PEP) segment accounted for the majority of market share in 2018 and is expected to exhibit a prominent growth rate in the near future, owing to the fact that it is the most used airway clearance systems used for the treatment of cystic fibrosis. However, oscillating PEP device segment is anticipated to grow at the fastest rate during the forecast period

By application, the bronchiectasis segment dominated the airway clearance market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the surge in surge in incidence of the disease across the globe. For instance, according to British Lung Foundation, around 210,000 people in the UK were living with bronchiectasis in 2016.

According to Onkar Sumant, Assistant Manager, Healthcare, “The growth of the airway clearance market is due to the surge in respiratory disorders across the globe.

KEY FINDINGS OF THE STUDY
  • By type, the positive expiratory pressure (PEP) segment accounted for the highest market share of 27% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
  • By region, North America was the major shareholder and accounted for the highest share of 44% in 2018.
  • By application, neuromuscular segment is expected to grow at a CAGR of 5.4% during the forecast period.
  • By end user, the hospitals segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.

Comprehensive competitive analysis and profiles of major market players such as Allergan plc, Dymedso Inc., Electromed Inc., Ltd., General Physiotherapy IncHill-Rom Holdings, Inc., International Biophysical Corporation, Koninklijke Philips N.V. (Philips), Monaghan Medical Corporation, Inc., and PARI GmbH, Thayer Medical. are provided in this report.
Note: Product cover images may vary from those shown
  • Allergan plc
  • Dymedso Inc.
  • Electromed Inc. Ltd.
  • General Physiotherapy IncHill-Rom Holdings Inc.
  • International Biophysical Corporation
  • Koninklijke Philips N.V. (Philips)
  • Monaghan Medical Corporation Inc.
  • PARI GmbH
  • Thayer Medical
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...